Population
Patients with human heart disease, particularly chronic heart failure
Design
Review
Authors
Loading...
Native β1AR assays may be required for reliable autoantibody detection; leaves open targeted HF therapies.
Reliable detection of agonistic β1AR autoantibodies using native cell-based assays is essential for implementing targeted therapies in heart failure.
Bornholz et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: